Cancer Treatment

JUL 11, 2026 · JOURNAL ARTICLE

Artesunate-loaded bovine serum albumin nanoplatform with metal-polyphenol network coating for ferroptosis-driven breast cancer therapy.

International Journal of Pharmaceutics: X

Preclinical proof-of-concept in cell and animal models showing a novel nanoparticle formulation induces ferroptosis and tumor inhibition, but lacks human efficacy data, safety characterization, and direct comparator controls.

JUL 9, 2026 · JOURNAL ARTICLE

A visualizable mitochondrial-targeted Chlorambucil prodrug for enhancing anti-hepatoma efficacy.

Pharmaceutical Science Advances

Preclinical in vitro and in vivo study of a novel prodrug showing proof-of-concept mitochondrial targeting and selectivity, but lacking human trials, quantified efficacy metrics, or comparative clinical outcome data.

JUN 4, 2026 · JOURNAL ARTICLE

Leveraging the bacteria for enhanced cancer immunotherapy: from a perspective of synthetic biology.

Cancer Biology & Therapy

This is a narrative review synthesizing existing knowledge on synthetic biology approaches to bacterial cancer immunotherapy, without reporting original experimental data, primary endpoints, or comparative efficacy claims.

MAR 11, 2026 · JOURNAL ARTICLE

Photodynamic therapy based on indomethacin-conjugated photosensitizers: targeting cyclooxygenase-2 in cancer treatment.

Medical Gas Research

Review discussing a therapeutic strategy combining indomethacin with photosensitizers to enhance photodynamic therapy by targeting COX-2, without presenting primary clinical or experimental data.